Celldex Therapeutics (CLDX) Operating Margin Growth (5y) (2015 - 2026)
Celldex Therapeutics (CLDX) Operating Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Celldex Therapeutics |
2.16 Bn |
2.16 Bn |
-1.44 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-56.05 Mn |
| Dec 31, 2025 |
-7.14 Mn |
| Jun 30, 2025 |
-393,186.00 |
| Mar 31, 2025 |
-831,236.00 |
| Dec 31, 2024 |
-330,388.00 |
| Sep 30, 2024 |
53,570.00 |
| Jun 30, 2024 |
-13,990.00 |
| Mar 31, 2024 |
-2.48 Mn |
| Dec 31, 2023 |
-46,567.00 |
| Sep 30, 2023 |
-189,338.00 |
| Jun 30, 2023 |
-1.18 Mn |
| Mar 31, 2023 |
-41,600.00 |
| Dec 31, 2022 |
-335,244.00 |
| Sep 30, 2022 |
-599,041.00 |
| Jun 30, 2022 |
-2.16 Mn |
| Mar 31, 2022 |
-1.11 Mn |
| Sep 30, 2021 |
-1.23 Mn |
| Jun 30, 2021 |
194,396.00 |
| Mar 31, 2021 |
31,109.00 |
| Dec 31, 2020 |
121,350.00 |
